Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• ‘Shocking imbalance’ of COVID-19 vaccine distribution underscores inequity Caitlyn Stulpin
• Questions remain after WHO team visits Wuhan looking for answers to SARS-CoV-2 Arnon Shimshony, DVM
• Adenovirus type 4 infections tripled among civilians in last decade Eamon N. Dreisbach
• Antibiotic prescription trends shift due to telehealth during COVID-19 Madison Weller
• As CDC, FDA lift pause of J&J vaccine, poll indicates ‘eroded confidence’ in shot Eamon N. Dreisbach
• Biden plan seeks to bolster HIV response, opening door to stronger post-pandemic US Rajesh Gandhi, MD
• Cities face barriers to vaccinating people experiencing homelessness Eamon N. Dreisbach
• Contact precautions reduce MRSA transmission by almost 50% in VA hospitals Eamon N. Dreisbach
• COVID-19 outbreak at skilled nursing facility linked to unvaccinated worker Caitlyn Stulpin
• ED visits may represent opportunity to de-label false penicillin allergies Madison Weller
• FDA rescinds EUA for bamlanivimab monotherapy as COVID-19 treatment
• Hospital infection control program sees 500% increase in calls during pandemic Eamon N. Dreisbach
• Income limits for SNAP eligibility inversely associated with new HIV diagnoses Caitlyn Stulpin
• ‘Landmark discovery’: C. auris isolated from environment for first time Caitlyn Stulpin
• Leaving middle seat vacant on planes can reduce SARS-CoV-2 exposure, study shows Eamon N. Dreisbach
• Malaria vaccine candidate 77% efficacious in trial, researchers report Ken Downey Jr.
• People experiencing homelessness less likely to use INSTI-based ART for HIV Eamon N. Dreisbach
• Pfizer and BioNTech say COVID-19 vaccine protects adolescents, plan to submit data to FDA Ken Downey Jr.
• Prescribing for recurrent UTIs often does not align with IDSA guidelines, study finds Caitlyn Stulpin
• Q&A: Reduced efficacy of COVID-19 vaccines in transplant recipients Eamon N. Dreisbach
• Q&A: What is herd immunity and what will happen to SARS-CoV-2 if we reach it? Eamon N. Dreisbach
• RCT shows tedizolid may be effective alternative to linezolid for gram-positive HABP, VABP Caitlyn Stulpin
• Results of ‘truly disappointing’ HIV vaccine trial published Eamon N. Dreisbach
• Secnidazole ‘highly effective’ for trichomoniasis in US women Caitlyn Stulpin
• Stopping contact precautions did not impact nosocomial MRSA or VRE, study finds Eamon N. Dreisbach
• ‘Strong likelihood’ Campylobacter can be transmitted via sexual contact Caitlyn Stulpin
• Study finds some household contacts resistant to TB infection Caitlyn Stulpin
• Traditional definition underestimates burden of health care-associated flu Caitlyn Stulpin
• US dentists prescribe twice as many antibiotics as dentists in Australia Caitlyn Stulpin
• US reports record number of STDs for 6th straight year Caitlyn Stulpin
• Vietnam records first case of Dracunculus worm infection Ken Downey Jr.
• WHO: No antibiotic in development sufficiently addresses drug resistance Caitlyn Stulpin
• Will we need COVID-19 booster shots? Caitlyn Stulpin
• Will equity issues persist for boosters or variant-specific doses of COVID-19 vaccine? William Schaffner, MD
• ACP recommends shorter antibiotic courses for common bacterial infections Janel Miller
• Hooked on ID with Gregory A. Poland, MD, MACP, FIDSA, FRCP
• ‘Meaningless’ urine culture results prompt clinicians to look for solutions Janel Miller
• VRE bloodstream infections increase in California hospitals amid COVID-19 Janel Miller
• Pandemic strains resources for HAI prevention and surveillance Kelly M. Percival, PharmD, BCPS, BCIDP